Attività scientifica


ULTIME PUBBLICAZIONI RILEVANTI

      1. Tarantini L, Barbati G, Cioffi G, McAlister FA, Ezekowitz JA, Mazzone C, Faganello G, Russo G, Grisolia EF, Di Lenarda A. Clinical implications of the CKD epidemiology collaboration (CKD-EPI) equation compared with the modification of diet in renal disease (MDRD) study equation for the estimation of renal dysfunction in patients with cardiovascular disease. Intern Emerg Med. 2015 Jun 30.
      2. Faganello G, Russo G, Pozzi M, Gigli M, Pagnan L, Di Lenarda A. .Pulmonary autograft dysfunction mimicking severe aortic stenosis. G Ital Cardiol (Rome). 2015 May;16(5):320-1
      3. Cioffi G, Viapiana O, Ognibeni F, Dalbeni A, Gatti D, Adami S, Mazzone C, Faganello G, Di Lenarda A, Rossini M. Prevalence and factors related to left ventricular systolic dysfunction in asymptomatic patients with rheumatoid arthritis : A prospective tissue Doppler echocardiography study. Herz. 2015 May 20. [Epub ahead of print]
      4. Faganello G, Cioffi G, Faggiano P, Candido R, Tarantini L, De Feo S, Di Lenarda A, de Simone G. Does metabolic syndrome worsen systolic dysfunction in diabetes? The shortwave study. Acta Diabetol. 2015; 52(1):143-51.
      5. Cioffi G, Pulignano G, Barbati G, Tarantini L, Del Sindaco D, Mazzone C, Russo G, Cherubini A, Faganello G, Stefenelli C, Ognibeni F, Senni M, Di Lenarda A. Reasons why patients suffering from chronic heart failure at very high risk for death survive. Int J Cardiol. 2014 Nov 15;177(1):213-8.
      6. Gaibazzi N, Sicari R, Agricola E, Cioffi G, Mazzone C, Albertini L, Faden G, Molinaro S, Regazzoli D, Di Lenarda A, Faggiano P. Cardiac calcification at transthoracic echocardiography predicts stress echo results: A multicentre study. Int J Cardiol. 2014 Apr 12.
      7. Senni M, Gavazzi A, Oliva F, Mortara A, Urso R, Pozzoli M, Metra M, Lucci D, Gonzini L, Cirrincione V, Montagna L, Di Lenarda A, Maggioni AP, Tavazzi L; IN HF Outcome Investigators. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry. Int J Cardiol. 2014 May 1;173(2):163-9.
      8. Aleksova A, Carriere C, Zecchin M, Barbati G, Vitrella G, Di Lenarda A,Sinagra G. New-onset left bundle branch block independently predicts long-term mortality in patients with idiopathic dilated cardiomyopathy: data from the Trieste Heart Muscle Disease Registry. Europace. 2014 Feb 18.
      9. Russo G, Cioffi G, Gori S, Tuccia F, Boccardi L, Khoury G, Lestuzzi C, Maurea N, Oliva S, Faggiano P, Tarantini L; ICARO (Italian CARdio-Oncological) Network. Role of hypertension on new onset congestive heart failure in patients receiving trastuzumab therapy for breast cancer. J Cardiovasc Med (Hagerstown). 2014Feb;15(2):141-6.
      10. Faden G, Viapiana O, Fischetti F, Faganello G, Gatti D, Tarantini L, Adami S, Tincani A, Di Lenarda A, Filippini M, Faggiano P, Cioffi G. Cardiovascular risk stratification and management of patients with rheumatoid arthritis in clinical practice: the “EPIDAURO registry”. Int J Cardiol. 2014; 172(2): 534-6
      11. Magrì D, Corrà U, Di Lenarda A, Cattadori G, Maruotti A, Iorio A, Mezzani A,Giannuzzi P, Mantegazza V, Gondoni E, Sinagra G, Piepoli MF, Fiorentini C,Agostoni P. cardiovascular mortality and chronotropic incompetence in systolicheart failure: the importance of a reappraisal of current cut-off criteria. Eur J Heart Fail. 2014 Feb;16(2):201-9.
      12. Mazzone C, Cioffi G, Faganello G, Faggiano P, Candido R, Cherubini A, Tarantini L, De Feo S, Di Lenarda A. Analysis of Left Atrial Performance in Patients with Type 2 Diabetes Mellitus without Overt Cardiac Disease and Inducible Ischemia: High Prevalence of Increased Systolic Force Related to Enhanced Left Ventricular Systolic Longitudinal Function. Echocardiography. 2015;32(2):221-8
      13. Merlo M, Pivetta A, Pinamonti B, Stolfo D, Zecchin M, Barbati G, Di Lenarda A,Sinagra G. Long-term prognostic impact of therapeutic strategies in patients with idiopathic dilated cardiomyopathy: changing mortality over the last 30 years. Eur J Heart Fail. 2014 Mar;16(3):317-24.
      14. Cioffi G, Faganello G, De Feo S, Berlinghieri N, Tarantini L, Di Lenarda A, Pinamonti B, Candido R, Faggiano P. Combined circumferential and longitudinal left ventricular systolic dysfunction in patients with type 2 diabetes mellitus without myocardial ischemia. Exp Clin Cardiol. 2013 Winter;18(1):e26-31.
      15. Giugliano RP, Ruff CT, Braunwald E, Murphy SA, Wiviott SD, Halperin JL, Waldo AL, Ezekowitz MD, Weitz JI, Špinar J, Ruzyllo W, Ruda M, Koretsune Y, Betcher J, Shi M, Grip LT, Patel SP, Patel I, Hanyok JJ, Mercuri M, Antman EM; ENGAGE AF-TIMI 48 Investigators. Edoxaban versus warfarin in patients with atrial fibrillation. N Engl J Med. 2013 Nov 28;369(22):2093-104.
      16. Campbell N, Sinagra G, Jones KL, Slavov D, Gowan K, Merlo M, Carniel E, Fain PR, Aragona P, Di Lenarda A, Mestroni L, Taylor MR. Whole exome sequencing identifies a troponin T mutation hot spot in familial dilated cardiomyopathy. PLoS One. 2013 Oct 29;8(10):e78104.
      17. Merlo M, Sinagra G, Carniel E, Slavov D, Zhu X, Barbati G, Spezzacatene A, Ramani F, Salcedo E, Di Lenarda A, Mestroni L, Taylor MR; Familial Cardiomyopathy Registry. Poor prognosis of rare sarcomeric gene variants in patients with dilated cardiomyopathy. Clin Transl Sci. 2013 Dec;6(6):424-8.
      18. Anzini M, Merlo M, Sabbadini G, Barbati G, Finocchiaro G, Pinamonti B, Salvi A, Perkan A, Di Lenarda A, Bussani R, Bartunek J, Sinagra G. Long-term evolution and prognostic stratification of biopsy-proven active myocarditis. Circulation.2013 Nov 26;128(22):2384-94
      19. Cattadori G, Agostoni P, Corrà U, Di Lenarda A, Sinagra G, Veglia F, Salvioni E, La Gioia R, Scardovi AB, Emdin M, Metra M, Limongelli G, Raimondo R, Re F,Guazzi M, Belardinelli R, Parati G, Magrì D, Fiorentini C, Mezzani A, Scrutinio D, Pacileo G, Apostolo A, Iorio A, Paolillo S, Palermo P, Contini M, Giannuzzi P, Battaia E, Cicoira M, Passino C, Piepoli MF; MECKI score research group. Severe heart failure prognosis evaluation for transplant selection in the era of beta-blockers: role of peak oxygen consumption. Int J Cardiol. 2013 Oct 12;168(5):5078-81
      20. Russo G, Cioffi G, Tarantini L, Cherubini A, Faganello G, Mazzone C, Barbati G, Candido R, Faggiano P, Di Lenarda A. Does renal function influence the prognostic impact of type 2 diabetes mellitus in patients with chronic heart failure and left ventricular dysfunction? IJC Metabolic & Endocrine. 01/2014
      21. Mazzone C, Cioffi G, Faganello G, Cherubini A, Tarantini L, Di Lenarda A,Russo TE, Selmi A, Stefenelli C, Furlanello F. Left atrial work in patients with stable chronic heart failure: factors associated and prognostic role. Echocardiography. 2015;32(2):221-8
      22. Faden G, Faganello G, De Feo S, Berlinghieri N, Tarantini L, Di Lenarda A,Faggiano P, Cioffi G. The increasing detection of asymptomatic left ventricular dysfunction in patients with type 2 diabetes mellitus without overt cardiac disease: data from the SHORTWAVE study. Diabetes Res Clin Pract. 2013; 101(3):309-16
      23. Agostoni P, Corrà U, Cattadori G, Veglia F, Battaia E, La Gioia R, Scardovi AB, Emdin M, Metra M, Sinagra G, Limongelli G, Raimondo R, Re F, Guazzi M, Belardinelli R, Parati G, Magrì D, Fiorentini C, Cicoira M, Salvioni E, Giovannardi M, Mezzani A, Scrutinio D, Di Lenarda A, Mantegazza V, Ricci R, Apostolo A, Iorio A, Paolillo S, Palermo P, Contini M, Vassanelli C, Passino C, Piepoli MF; MECKI Score Research Group. Prognostic value of indeterminable anaerobic threshold in heart failure. Circ Heart Fail. 2013 Sep 1;6(5):977-87.
      24. Cioffi G, Mortara A, Di Lenarda A, Oliva F, Lucci D, Senni M, Cacciatore G, Chinaglia A, Tarantini L, Metra M, Maggioni AP, Tavazzi L; Italian Acute Heart Failure Survey. Clinical features, and in-hospital and 1-year mortalities of patients with acute heart failure and severe renal dysfunction. Data from the Italian Registry IN-HF Outcome. Int J Cardiol. 2013 Oct 9;168(4):3691-7.
      25. Cioffi G, Faggiano P, Lucci D, Maggioni AP, Manicardi V, Travaglini A, Girfoglio D, Masson S, Giorda CB, Velussi M, Di Lenarda A, Verdecchia P, Comaschi M. Left ventricular dysfunction and outcome at two-year follow-up in patients with type 2 diabetes: The DYDA study. Diabetes Res Clin Pract. 2013 Aug;101(2):236-42.
      26. Poppe KK, Squire IB, Whalley GA, Køber L, McAlister FA, McMurray JJ, Pocock S, Earle NJ, Berry C, Doughty RN; Meta-Analysis Global Group in Chronic Heart Failure. Known and missing left ventricular ejection fraction and survival in patients with heart failure: a MAGGIC meta-analysis report. Eur J Heart Fail. 2013 Nov;15(11):1220-7.
      27. Tarantini L, Di Lenarda A. [Life is short, art long, opportunity fleeting, experiment treacherous, judgment difficult]. G Ital Cardiol (Rome). 2013 Jun;14(6):463-5.
      28. Misuraca G, Di Tano G, Camerini A, Cloro C, Gorini M; Ricercatori IN-HF Outcome. [Data from the IN-HF Outcome registry]. G Ital Cardiol (Rome). 2012 May;13(5 Suppl 1):23S-30S.
      29. Russo G, Cherubini A, Faganello G, Candido R, Di Lenarda A. [Risk factors for heart failure in women: diabetes]. G Ital Cardiol (Rome). 2012 May;13(5 Suppl 1):12S-17S. Italian.
      30. Faganello G, Faggiano P, Candido R, Tarantini L, Di Lenarda A, De Feo S, Cioffi G. The worrisome liaison between left ventricular systolic dysfunction and mitral annulus calcification in type 2 diabetes without coronary artery disease: data from the SHORTWAVE study. Nutr Metab Cardiovasc Dis. 2013 Dec;23(12):1188-94
      31. Tavazzi L, Senni M, Metra M, Gorini M, Cacciatore G, Chinaglia A, Di Lenarda A, Mortara A, Oliva F, Maggioni AP; IN-HF (Italian Network on Heart Failure) Outcome Investigators. Multicenter prospective observational study on acute and chronic heart failure: one-year follow-up results of IN-HF (Italian Network on Heart Failure) outcome registry. Circ Heart Fail. 2013 May;6(3):473-81
      32. Cioffi G, Mazzone C, Faggiano P, Tarantini L, Di Lenarda A, Russo TE, Selmi A, Stefenelli C, Furlanello F. Prognostic stratification by conventional echocardiography of patients with aortic stenosis: the "CAIMAN-ECHO score". Echocardiography. 2013 Apr;30(4):367-77.
      33. Del Sindaco D, Pulignano G, Di Lenarda A, Tarantini L, Cioffi G, Tolone S, Tinti MD, Monzo L, Barbati G, Minardi G. Role of a multidisciplinary program in improving outcomes in cognitively impaired heart failure older patients. Monaldi Arch Chest Dis. 2012 Mar;78(1):20-8.
      34. oimas S, Zacchigna S, Merlo M, Buiatti A, Anzini M, Dreas L, Salvi A, Di Lenarda A, Giacca M, Sinagra G. Idiopathic dilated cardiomyopathy and persistent viral infection: lack of association in a controlled study using a quantitative assay. Heart Lung Circ. 2012 Dec;21(12):787-93.
      35. liva F, Mortara A, Cacciatore G, Chinaglia A, Di Lenarda A, Gorini M, Metra M, Senni M, Maggioni AP, Tavazzi L; IN-HF Outcome Investigators. Acute heart failure patient profiles, management and in-hospital outcome: results of the Italian Registry on Heart Failure Outcome. Eur J Heart Fail. 2012 Nov;14(11):1208-17
      36. Agostoni P, Corrà U, Cattadori G, Veglia F, La Gioia R, Scardovi AB, Emdin M, Metra M, Sinagra G, Limongelli G, Raimondo R, Re F, Guazzi M, Belardinelli R, Parati G, Magrì D, Fiorentini C, Mezzani A, Salvioni E, Scrutinio D, Ricci R, Bettari L, Di Lenarda A, Pastormerlo LE, Pacileo G, Vaninetti R, Apostolo A, Iorio A, Paolillo S, Palermo P, Contini M, Confalonieri M, Giannuzzi P, Passantino A, Cas LD, Piepoli MF, Passino C; MECKI Score Research Group. Metabolic exercise test data combined with cardiac and kidney indexes, the MECKI score: a multiparametric approach to heart failure prognosis. Int J Cardiol. 2013 Sep 10;167(6):2710-8
      37. Russo G, Cioffi G, Di Lenarda A, Tuccia F, Bovelli D, Di Tano G, Alunni G, Gori S, Faggiano P, Tarantini L. Role of renal function on the development of cardiotoxicity associated with trastuzumab-based adjuvant chemotherapy for early breast cancer. Intern Emerg Med. 2012 Oct;7(5):439-46.
      38. Tarantini L, Gori S, Faggiano P, Pulignano G, Simoncini E, Tuccia F, Ceccherini R, Bovelli D, Lestuzzi C, Cioffi G; ICARO (Italian CARdio-Oncologic) Network. Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: a multicenter cohort analysis. Ann Oncol. 2012
      39. orio A, Magrì D, Paolillo S, Salvioni E, Di Lenarda A, Sinagra G, Agostoni P, Sciomer S. Rationale for cardiopulmonary exercise test in the assessment of surgical risk. J Cardiovasc Med (Hagerstown). 2013 Apr;14(4):254-61.
      40. iansante C, Fiotti N, Altamura N, Pitacco P, Consoloni L, Scardi S, Mazzone C, Grassi G, Pandullo C, Di Lenarda A. Oral anticoagulation and VKORC1 polymorphism in patients with a mechanical heart prosthesis: a 6-year follow-up. J Thromb Thrombolysis. 2012 Nov;34(4):506-12.
      41. Ghio S, Temporelli PL, Marsan NA, Poppe K, Giannuzzi P, Dini FL, Rossi A, Doughty RN, Whalley G; MeRGE HF collaborators. Prognostic implications of left ventricular dilation in patients with nonischemic heart failure: interactions with restrictive filling pattern and mitral regurgitation. Congest Heart Fail. 2012 Jul-Aug;18(4):198-204.
      42. Herman DS, Lam L, Taylor MR, Wang L, Teekakirikul P, Christodoulou D, Conner L, DePalma SR, McDonough B, Sparks E, Teodorescu DL, Cirino AL, Banner NR, Pennell DJ, Graw S, Merlo M, Di Lenarda A, Sinagra G, Bos JM, Ackerman MJ, Mitche l RN, Murry CE, Lakdawala NK, Ho CY, Barton PJ, Cook SA, Mestroni L, Seidman JG, Seidman CE. Truncations of titin causing dilated cardiomyopathy. N Engl J Med. 2012 Feb 16;366(7):619-28.
      43. Di Lenarda A, Pulignano G. [The Tele-HF study]. G Ital Cardiol (Rome). 2012 Feb;13(2):75-80.
      44. Tarantini L, Cioffi G, Gori S, Tuccia F, Boccardi L, Bovelli D, Lestuzzi C, Maurea N, Oliva S, Russo G, Faggiano P; Italian Cardio-Oncologic Network. Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer. J Card Fail. 2012 Feb;18(2):113-9.
      45. Zecchin M, Merlo M, Pivetta A, Barbati G, Lutman C, Gregori D, Serdoz LV, Bardari S, Magnani S, Di Lenarda A, Proclemer A, Sinagra G. How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with "SCD-HeFT criteria?". Am J Cardiol. 2012 Mar 1;109(5):729-35.
      46. Senni M, Parrella P, De Maria R, Cottini C, Böhm M, Ponikowski P, Filippatos G, Tribouilloy C, Di Lenarda A, Oliva F, Pulignano G, Cicoira M, Nodari S, Porcu M, Cioffi G, Gabrielli D, Parodi O, Ferrazzi P, Gavazzi A. Predicting heart failure outcome from cardiac and comorbid conditions: the 3C-HF score. Int J Cardiol. 2013 Feb 20;163(2):206-11.
      47. de Simone G, Chinali M, Mureddu GF, Cacciatore G, Lucci D, Latini R, Masson S, Vanasia M, Maggioni AP, Boccanelli A; AREA-in-CHF Investigators. Effect of canrenone on left ventricular mechanics in patients with mild systolic heart failure and metabolic syndrome: the AREA-in-CHF study. Nutr Metab Cardiovasc Dis. 2011 Oct;21(10):783-91.
      48. Cioffi G, Faggiano P, Lucci D, Di Lenarda A, Mureddu GF, Tarantini L, Verdecchia P, Comaschi M, Giorda CB, Velussi M, Chinali M, Latini R, Masson S, De Simone G; DYDA Investigators. Inappropriately high left ventricular mass in patients with type 2 diabetes mellitus and no overt cardiac disease. The DYDA study. J Hypertens. 2011 Oct;29(10):1994-2003.
      49. Meta-analysis Global Group in Chronic Heart Failure (MAGGIC). The survival of patients with heart failure with preserved or reduced left ventricular ejection fraction: an individual patient data meta-analysis. Eur Heart J. 2012 Jul;33(14):1750-7. doi: 10.1093/eurheartj/ehr254. Epub 2011 Aug 6. Review. PubMed PMID: 21821849.
      50. Cioffi G, Giorda CB, Chinali M, Di Lenarda A, Faggiano P, Lucci D, Maggioni AP, Masson S, Mureddu GF, Tarantini L, Velussi M, Comaschi M; DYDA Investigators. Analysis of midwall shortening reveals high prevalence of left ventricular myocardial dysfunction in patients with diabetes mellitus: the DYDA study. Eur J Prev Cardiol. 2012 Oct;19(5):935-43.
      51. cNair WP, Sinagra G, Taylor MR, Di Lenarda A, Ferguson DA, Salcedo EE, Slavov D, Zhu X, Caldwell JH, Mestroni L; Familial Cardiomyopathy Registry Research Group. SCN5A mutations associate with arrhythmic dilated cardiomyopathy and commonly localize to the voltage-sensing mechanism. J Am Coll Cardiol. 2011
      52. Berchialla P, Foltran F, Di Lenarda A, Barbati G, Franchin L, Salvatore L, Gregori D. Hospitalization rate as a proxy for the quality of life evaluation: the case of dilated cardiomiopathy. J Prev Med Hyg. 2010 Dec;51(4):152-6.
      53. Tarantini L, Oliva F, Cantoni S, Cioffi G, Agnoletto V, Alunni G, De Cian F, Di Lenarda A, Lucci D, Pulignano G, Scelsi L, Maggioni AP, Tavazzi L. Prevalence and prognostic role of anaemia in patients with acute heart failure and preserved or depressed ventricular function. Intern Emerg Med. 2013 Mar;8(2):147-55.
      54. Serdoz LV, Daleffe E, Merlo M, Zecchin M, Barbati G, Pecora D, Pinamonti B, Fantoni C, Lupo P, Di Lenarda A, Sinagra G, Cappato R. Predictors for restoration of normal left ventricular function in response to cardiac resynchronization therapy measured at time of implantation. Am J Cardiol. 2011 Jul 1;108(1):75-80.
      55. Pyxaras SA, Merlo M, Barbati G, Delise M, Perkan A, Di Lenarda A, Sinagra G. Prognostic role of hemodynamic evaluation at rest and at maximum workload in patients with idiopathic dilated cardiomyopathy. Int J Cardiol. 2011 Jul 1;150(1):97-9.
      56. Giorda CB, Cioffi G, de Simone G, Di Lenarda A, Faggiano P, Latini R, Lucci D, Maggioni AP, Tarantini L, Velussi M, Verdecchia P, Comaschi M; DYDA Investigators. Predictors of early-stage left ventricular dysfunction in type 2 diabetes: results of DYDA study. Eur J Cardiovasc Prev Rehabil. 2011Jun;18(3):415-23.
      57. Merlo M, Pyxaras SA, Pinamonti B, Barbati G, Di Lenarda A, Sinagra G. Prevalence and prognostic significance of left ventricular reverse remodeling in dilated cardiomyopathy receiving tailored medical treatment. J Am Coll Cardiol. 2011 Mar 29;57(13):1468-76
      58. Pinamonti B, Dragos AM, Pyxaras SA, Merlo M, Pivetta A, Barbati G, Di Lenarda A, Morgera T, Mestroni L, Sinagra G. Prognostic predictors in arrhythmogenic right ventricular cardiomyopathy: results from a 10-year registry. Eur Heart J. 2011 May;32(9):1105-13.
      59. Tarantini L, Cioffi G, Pulignano G, Del Sindaco D, Aspromontes N, Valle R, Di Tano G, Misuraca G, Clemenza F, Di Lenarda A. [Heart failure in primary care in Italy: analysis of management and needs by general practitioners]. G Ital Cardiol (Rome). 2010 Sep;11(9):680-7.
      60. Pasini E, Pirelli S, Di Lenarda A, Dioguardi FS, Maseri A. [The evolution of medical research: from trials to tailored therapy]. G Ital Cardiol (Rome). 2010 Oct;11(10):761-6. Review.
      61. Cioffi G, Gerdts E, Cramariuc D, Tarantini L, Di Lenarda A, Pulignano G, Sindaco DD, Stefenelli C, de Simone G. Left atrial size and force in patients with systolic chronic heart failure: Comparison with healthy controls and different cardiac diseases. Exp Clin Cardiol. 2010 Fall;15(3):e45-51.
      62. Di Lenarda A, Tarantini L, Cherubini A, Pirozzi F, Santangelo S, Bobbo M, Sinagra G. [Prevention of heart failure]. G Ital Cardiol (Rome). 2010 May;11(5 Suppl 3):81S-86S. Italian. PubMed PMID: 20879488.
      63. Chicco D, Taddio A, Sinagra G, Di Lenarda A, Ferrara F, Moretti M, Martelossi S, Di Toro N, Ventura A, Not T. Speeding up coeliac disease diagnosis in cardiological settings. Arch Med Sci. 2010 Oct;6(5):728-32.
      64. Mortara A, Oliva F, Di Lenarda A. [Current perspectives in telemonitoring and devices in chronic heart failure patients: lights and shadows]. G Ital Cardiol (Rome). 2010 May;11(5 Suppl 2):33S-37S. Italian. PubMed PMID: 20873466.
      65. Pulignano G, Del Sindaco D, Di Lenarda A, Tarantini L, Cioffi G, Gregori D, Tinti MD, Monzo L, Minardi G. Usefulness of frailty profile for targeting older heart failure patients in disease management programs: a cost-effectiveness, pilot study. J Cardiovasc Med (Hagerstown). 2010 Oct;11(10):739-47.
      66. Aleksova A, Barbati G, Merlo M, Stolfo D, Sabbadini G, Di Lenarda A, Sinagra G. Deleterious impact of mild anemia on survival of young adult patients (age 45 ± 14 years) with idiopathic dilated cardiomyopathy: data from the Trieste Cardiomyopathies Registry. Heart Lung. 2011 Sep-Oct;40(5):454-61.
      67. Aleksova A, Merlo M, Zecchin M, Sabbadini G, Barbati G, Vitrella G, Di Lenarda A, Sinagra G. Impact of atrial fibrillation on outcome of patients with idiopathic dilated cardiomyopathy: data from the Heart Muscle Disease Registry of Trieste. Clin Med Res. 2010 Dec;8(3-4):142-9..
      68. Moretti M, Merlo M, Barbati G, Di Lenarda A, Brun F, Pinamonti B, Gregori D, Mestroni L, Sinagra G. Prognostic impact of familial screening in dilated cardiomyopathy. Eur J Heart Fail. 2010 Sep;12(9):922-7.
      69. Pinamonti B, Merlo M, Nangah R, Korcova R, Di Lenarda A, Barbati G, Sinagra G. The progression of left ventricular systolic and diastolic dysfunctions in hypertrophic cardiomyopathy: clinical and prognostic significance. J Cardiovasc Med (Hagerstown). 2010 Sep;11(9):669-77. doi: 10.2459/JCM.0b013e3283383355. PubMed PMID: 20216227.
      70. Barbati G, Merlo M, Marocco P, Gregori D, Sabbadini G, Lattuada L, Ginanneschi U, Sinagra G, Di Lenarda A. Relative survival in dilated cardiomyopathy: a stratification study of long-term outcome to evaluate life insurance cover. J Insur Med. 2009;41(2):117-26.
      71. Rossi A, Temporelli PL, Quintana M, Dini FL, Ghio S, Hillis GS, Klein AL, Marsan NA, Prior DL, Yu CM, Poppe KK, Doughty RN, Whalley GA; MeRGE Heart Failure Collaborators. Independent relationship of left atrial size and mortality in patient with heart failure: an individual patient meta-analysis of longitudinal data (MeRGE Heart Failure). Eur J Heart Fail. 2009 Oct;11(10):929-36.
      72. Ambrosio G, Di Lenarda A, Fedele F, Gabrielli D, Metra M, Oliva F, Perna G, Senni M, De Maria R. [Inotrope therapy in acute heart failure: a critical review of clinical and scientific evidence for levosimendan in the context of traditional treatment]. G Ital Cardiol (Rome). 2009 Jul;10(7):422-33. Review.
      73. Metra M, Eichhorn E, Abraham WT, Linseman J, Böhm M, Corbalan R, DeMets D, De Marco T, Elkayam U, Gerber M, Komajda M, Liu P, Mareev V, Perrone SV, Poole-Wilson P, Roecker E, Stewart J, Swedberg K, Tendera M, Wiens B, Bristow MR; ESSENTIAL Investigators. Effects of low-dose oral enoximone administration on mortality, morbidity, and exercise capacity in patients with advanced heart failure:the randomized, double-blind, placebo-controlled, parallel group ESSENTIAL trials. Eur Heart J. 2009 Dec;30(24):3015-26.
      74. Scardi S, Mazzone C, Di Lenarda A. [Adherence to cardioprotective medications in coronary heart disease]. G Ital Cardiol (Rome). 2009 Apr;10(4):241-8. Review.
      75. Aleksova A, Sabbadini G, Merlo M, Pinamonti B, Barbati G, Zecchin M, Bussani R, Silvestri F, Iorio AM, Stolfo D, Dal Ferro M, Dragos AM, Meringolo G, Pyxaras S, Lo Giudice F, Perkan A, di Lenarda A, Sinagra G. Natural history of dilated cardiomyopathy: from asymptomatic left ventricular dysfunction to heart failure--a subgroup analysis from the Trieste Cardiomyopathy Registry. J Cardiovasc Med (Hagerstown). 2009 Sep;10(9):699-705.
      76. Boccanelli A, Mureddu GF, Cacciatore G, Clemenza F, Di Lenarda A, Gavazzi A, Porcu M, Latini R, Lucci D, Maggioni AP, Masson S, Vanasia M, de Simone G; AREA IN-CHF Investigators. Anti-remodelling effect of canrenone in patients with mild chronic heart failure (AREA IN-CHF study): final results. Eur J Heart Fail. 2009 Jan;11(1):68-76.
      77. Tarantini L, Cioffi G, Di Lenarda A, Valle R, Pulignano G, Del Sindaco D, Frigo G, Soravia G, Tessier R, Catania G. [Screening for asymptomatic left ventricular systolic dysfunction in high-risk patients. Preliminary experience with a program based on the use of ECG and natriuretic peptide]. G Ital Cardiol (Rome). 2008 Dec;9(12):835-43. Italian. PubMed PMID: 19119693.
      78. Agostoni P, Emdin M, Corrà U, Veglia F, Magrì D, Tedesco CC, Berton E, Passino C, Bertella E, Re F, Mezzani A, Belardinelli R, Colombo C, La Gioia R, Vicenzi M, Giannoni A, Scrutinio D, Giannuzzi P, Tondo C, Di Lenarda A, Sinagra G, Piepoli MF, Guazzi M. Permanent atrial fibrillation affects exercise capacity in chronic heart failure patients. Eur Heart J. 2008 Oct;29(19):2367-72.
      79. Sinagra G, Moretti M, Di Lenarda A, Pinamonti B, Salvi A, Silvestri F, Bussani R, Camerini F. [Cardiomyopathies 2008. Rethinking the issue in light of the recent American Heart Association and European Society of Cardiology statements]. G Ital Cardiol (Rome). 2008 May;9(5):309-13.
      80. Meta-analysis Research Group in Echocardiography (MeRGE) Heart Failure Collaborators, Doughty RN, Klein AL, Poppe KK, Gamble GD, Dini FL, Møller JE, Quintana M, Yu CM, Whalley GA. Independence of restrictive filling pattern and LV ejection fraction with mortality in heart failure: an individual patient meta-analysis. Eur J Heart Fail. 2008 Aug;10(8):786-92.
      81. Sinagra G, Di Lenarda A, Moretti M, Mestroni L, Pinamonti B, Perkan A, Salvi A, Pyxaras S, Bussani R, Silvestri F, Camerini F. The challenge of cardiomyopathies in 2007. J Cardiovasc Med (Hagerstown). 2008 Jun;9(6):545-54.
      82. Zecchin M, Di Lenarda A, Gregori D, Merlo M, Pivetta A, Vitrella G, Sabbadini G, Mestroni L, Sinagra G. Are nonsustained ventricular tachycardias predictive of major arrhythmias in patients with dilated cardiomyopathy on optimal medical treatment? Pacing Clin Electrophysiol. 2008 Mar;31(3):290-9.